Manuela Ferracin
Ferracin, Manuela
VIAF ID: 307339733 (Personal)
Permalink: http://viaf.org/viaf/307339733
Preferred Forms
-
200 _ 1 ‡a Ferracin ‡b , Manuela
-
100 0 _ ‡a Manuela Ferracin
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia |
![]() |
Basal Cell Carcinoma: A Comprehensive Review |
![]() |
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations |
![]() |
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. |
![]() |
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer |
![]() |
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma |
![]() |
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis |
![]() |
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC. |
![]() |
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. |
![]() |
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers |
![]() |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma |
![]() |
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment |
![]() |
Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications. |
![]() |
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway |
![]() |
Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer |
![]() |
Estrogen Receptors and Melanoma: A Review |
![]() |
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation |
![]() |
Extensive modulation of a set of microRNAs in primary glioblastoma |
![]() |
Familial cancer associated with a polymorphism in ARLTS1 |
![]() |
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes |
![]() |
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients |
![]() |
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians |
![]() |
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer |
![]() |
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. |
![]() |
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. |
![]() |
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology |
![]() |
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells |
![]() |
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis |
![]() |
Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: a clinical and ultrasonographic study. |
![]() |
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. |
![]() |
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC |
![]() |
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. |
![]() |
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis |
![]() |
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis |
![]() |
Micro-RNA profiling in kidney and bladder cancers |
![]() |
Micromarkers: miRNAs in cancer diagnosis and prognosis. |
![]() |
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality |
![]() |
MicroRNA e tumori umani / Manuela Ferracin ; tutore: Massimo Negrini |
![]() |
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation. |
![]() |
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis |
![]() |
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy--comparison with human epileptic samples. |
![]() |
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin |
![]() |
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy |
![]() |
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias |
![]() |
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome |
![]() |
A microRNA signature of hypoxia |
![]() |
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters |
![]() |
MicroRNAs as biomarker of Parkinson disease? Small but mighty. |
![]() |
MicroRNAs dysregulation in human malignant pleural mesothelioma |
![]() |
MicroRNAs in human cancer: from research to therapy |
![]() |
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia. |
![]() |
MicroRNAs: toward the clinic for breast cancer patients |
![]() |
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells |
![]() |
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression |
![]() |
miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. |
![]() |
miR-15 and miR-16 induce apoptosis by targeting BCL2 |
![]() |
MiR-15a and miR-16-1 cluster functions in human leukemia |
![]() |
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. |
![]() |
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs |
![]() |
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma |
![]() |
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy |
![]() |
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma |
![]() |
Modulation of mismatch repair and genomic stability by miR-155 |
![]() |
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer |
![]() |
Mutated beta-catenin evades a microRNA-dependent regulatory loop |
![]() |
The Non-Coding RNA Journal Club: Highlights on Recent Papers. |
![]() |
Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer |
![]() |
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 |
![]() |
Oncogenic role of miR-483-3p at the IGF2/483 locus |
![]() |
OncomiR detection in circulating body fluids: a PDMS microdevice perspective |
![]() |
The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma |
![]() |
Principles of MicroRNA Involvement in Breast Cancer |
![]() |
Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries. |
![]() |
Regulation of microRNA expression: the hypoxic component. |
![]() |
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD |
![]() |
The Sda Synthase B4GALNT2 Reduces Malignancy and Stemness in Colon Cancer Cell Lines Independently of Sialyl Lewis X Inhibition |
![]() |
Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells |
![]() |
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. |
![]() |
STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma |
![]() |
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. |
![]() |
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection |
![]() |
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. |
![]() |
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34 |
![]() |
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines |
![]() |
Tumor suppressor functions of ARLTS1 in lung cancers |
![]() |
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas |
![]() |
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis |
![]() |